Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Pediatric mast cell sarcoma of temporal bone with novel L799F (2395 C>T) KIT mutation, mimicking histiocytic neoplasm.

Kim YS, Wu H, Pawlowska AB, Bautista-Quach MA, Huang Q, Gaal K, Chang KL.

Am J Surg Pathol. 2013 Mar;37(3):453-8. doi: 10.1097/PAS.0b013e31828446d6.

PMID:
23388130
2.

Mast cell sarcoma of the scalp: the first sign of undisclosed systemic mastocytosis?

Falleti J, Borgia L, Lalinga AV, De Cecio R, Natella V, Patitucci G, Vita G.

Pathol Res Pract. 2012 Nov 15;208(11):683-6. doi: 10.1016/j.prp.2012.06.010. Epub 2012 Sep 7.

PMID:
22963840
3.

Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.

Noack F, Escribano L, Sotlar K, Nunez R, Schuetze K, Valent P, Horny HP.

Leuk Lymphoma. 2003 Feb;44(2):313-9.

PMID:
12688351
4.

Mast cell sarcoma in an infant: a case report and review of the literature.

Bautista-Quach MA, Booth CL, Kheradpour A, Zuppan CW, Rowsell EH, Weiss L, Wang J.

J Pediatr Hematol Oncol. 2013 May;35(4):315-20. doi: 10.1097/MPH.0b013e318279e392.

PMID:
23211696
5.

EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation.

Pan J, Quintás-Cardama A, Kantarjian HM, Akin C, Manshouri T, Lamb P, Cortes JE, Tefferi A, Giles FJ, Verstovsek S.

Blood. 2007 Jan 1;109(1):315-22. Epub 2006 Aug 15.

6.

Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.

Noack F, Sotlar K, Notter M, Thiel E, Valent P, Horny HP.

Leuk Lymphoma. 2004 Nov;45(11):2295-302.

PMID:
15512820
7.

Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.

Do I, Araujo ES, Kalil RK, Bacchini P, Bertoni F, Unni KK, Park YK.

Pathol Res Pract. 2007;203(3):127-34. Epub 2007 Feb 12.

PMID:
17298867
8.

Mast cell sarcoma: a rare and aggressive entity--report of two cases and review of the literature.

Georgin-Lavialle S, Aguilar C, Guieze R, Lhermitte L, Bruneau J, Fraitag S, Canioni D, Chandesris MO, Suarez F, Grandpeix-Guyodo C, Damaj G, Barete S, Aouba A, Fite C, Robert C, Gaulard P, Lortholary O, Tournilhac O, Dubreuil P, Hermine O.

J Clin Oncol. 2013 Feb 20;31(6):e90-7. doi: 10.1200/JCO.2012.41.9549. Epub 2012 Nov 5. Review. No abstract available.

PMID:
23129735
9.

Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma.

Chott A, Guenther P, Huebner A, Selzer E, Parwaresch RM, Horny HP, Valent P.

Am J Surg Pathol. 2003 Jul;27(7):1013-9.

PMID:
12826896
11.
12.

Systemic mastocytosis involving the gastrointestinal tract: clinicopathologic and molecular study of five cases.

Kirsch R, Geboes K, Shepherd NA, de Hertogh G, Di Nicola N, Lebel S, Mickys U, Riddell RH.

Mod Pathol. 2008 Dec;21(12):1508-16. doi: 10.1038/modpathol.2008.158. Epub 2008 Oct 17.

13.

KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients.

Garcia-Montero AC, Jara-Acevedo M, Teodosio C, Sanchez ML, Nunez R, Prados A, Aldanondo I, Sanchez L, Dominguez M, Botana LM, Sanchez-Jimenez F, Sotlar K, Almeida J, Escribano L, Orfao A.

Blood. 2006 Oct 1;108(7):2366-72. Epub 2006 Jun 1.

14.
15.

The Kit-activating mutation D816V enhances stem cell factor--dependent chemotaxis.

Taylor ML, Dastych J, Sehgal D, Sundstrom M, Nilsson G, Akin C, Mage RG, Metcalfe DD.

Blood. 2001 Aug 15;98(4):1195-9.

16.

Systemic mastocytosis (SM) and associated malignant bone marrow histiocytosis - a hitherto undescribed form of SM-AHNMD.

Rudzki Z, Sotlar K, Kudela A, Starzak-Gwóźdź J, Horny HP.

Pol J Pathol. 2011;62(2):101-4.

17.

Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor.

Georgin-Lavialle S, Lhermitte L, Suarez F, Yang Y, Letard S, Hanssens K, Feger F, Renand A, Brouze C, Canioni D, Asnafi V, Chandesris MO, Aouba A, Gineste P, Macintyre E, Mansfield CD, Moussy A, Lepelletier Y, Dubreuil P, Hermine O.

Eur J Haematol. 2012 Jul;89(1):47-52. doi: 10.1111/j.1600-0609.2012.01761.x. Epub 2012 Apr 28.

PMID:
22324351
18.

A new c-kit mutation in a case of aggressive mast cell disease.

Pignon JM, Giraudier S, Duquesnoy P, Jouault H, Imbert M, Vainchenker W, Vernant JP, Tulliez M.

Br J Haematol. 1997 Feb;96(2):374-6.

PMID:
9029028
19.

Mastocytosis: advances in diagnosis and treatment.

Hungness SI, Akin C.

Curr Allergy Asthma Rep. 2007 Jul;7(4):248-54. Review.

PMID:
17547845
20.

Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit.

Akin C, Brockow K, D'Ambrosio C, Kirshenbaum AS, Ma Y, Longley BJ, Metcalfe DD.

Exp Hematol. 2003 Aug;31(8):686-92.

PMID:
12901973
Items per page

Supplemental Content

Write to the Help Desk